Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fernandes

Showing results (1511-1520 of 1,632) with videos related to

Pageof 164
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk DiseaseMatthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Nature Communications|February 17, 2021
Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in miceIain W McNae, James Kinkead, Divya Malik, et al.
Blood Advances|October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Filippo Utro, Qing Wang, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Analysis of the Effect of the TRPC4/TRPC5 Blocker, ML204, in Sucrose-Induced Metabolic ImbalanceMizael C Araújo, Suzany H S Soczek, Jaqueline P Pontes, et al.
JCO Global Oncology|November 9, 2022
Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in BrazilCristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, et al.
Oncotarget|April 16, 2016
Characterization of selective and potent PI3Kδ inhibitor (PI3KDIN- 015) for B-Cell malignancesXiaochuan Liu, Aoli Wang, Xiaofei Liang, et al.
Toxins|February 25, 2025
Insights into the Role of Proteolytic and Adhesive Domains of Snake Venom Metalloproteinases from <i>Bothrops</i> spp. in the Control of <i>Toxoplasma gondii</i> InfectionSamuel C Teixeira, Thales A M Fernandes, Guilherme de Souza, et al.
The Canadian Journal of Cardiology|August 3, 2020
Physical Functioning, Mental Health, and Quality of Life in Different Congenital Heart Defects: Comparative Analysis in 3538 Patients From 15 CountriesPhilip Moons, Koen Luyckx, Corina Thomet, et al.
Blood|November 10, 2020
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Nature Genetics|October 31, 2020
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneityGabriela S Kinker, Alissa C Greenwald, Rotem Tal, et al.
Pageof 164

Showing results (1511-1520 of 1,632) with videos related to

Sort By:
Pageof 164
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk DiseaseMatthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Nature Communications|February 17, 2021
Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in miceIain W McNae, James Kinkead, Divya Malik, et al.
Blood Advances|October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Filippo Utro, Qing Wang, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Analysis of the Effect of the TRPC4/TRPC5 Blocker, ML204, in Sucrose-Induced Metabolic ImbalanceMizael C Araújo, Suzany H S Soczek, Jaqueline P Pontes, et al.
JCO Global Oncology|November 9, 2022
Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in BrazilCristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, et al.
Oncotarget|April 16, 2016
Characterization of selective and potent PI3Kδ inhibitor (PI3KDIN- 015) for B-Cell malignancesXiaochuan Liu, Aoli Wang, Xiaofei Liang, et al.
Toxins|February 25, 2025
Insights into the Role of Proteolytic and Adhesive Domains of Snake Venom Metalloproteinases from <i>Bothrops</i> spp. in the Control of <i>Toxoplasma gondii</i> InfectionSamuel C Teixeira, Thales A M Fernandes, Guilherme de Souza, et al.
The Canadian Journal of Cardiology|August 3, 2020
Physical Functioning, Mental Health, and Quality of Life in Different Congenital Heart Defects: Comparative Analysis in 3538 Patients From 15 CountriesPhilip Moons, Koen Luyckx, Corina Thomet, et al.
Blood|November 10, 2020
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Nature Genetics|October 31, 2020
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneityGabriela S Kinker, Alissa C Greenwald, Rotem Tal, et al.
Pageof 164